1
|
Bagot M, Muller M, Kim YH, Ortiz-Romero PL, Zinzani PL, Beylot-Barry M, Dalle S, Jacobsen E, Combalia A, Huen A, Mehta-Shah N, Khodadoust MS, Viotti J, Paiva C, Porcu P. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00590-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
2
|
Boyers D, Retat L, Jacobsen E, Avenell A, Aveyard P, Corbould E, Jaccard A, Cooper D, Robertson C, Aceves-Martins M, Xu B, Skea Z, de Bruin M. Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: a decision analysis model. Int J Obes (Lond) 2021; 45:2179-2190. [PMID: 34088970 PMCID: PMC8455321 DOI: 10.1038/s41366-021-00849-8] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Revised: 04/21/2021] [Accepted: 04/27/2021] [Indexed: 02/06/2023]
Abstract
OBJECTIVES To determine the most cost-effective weight management programmes (WMPs) for adults, in England with severe obesity (BMI ≥ 35 kg/m2), who are more at risk of obesity related diseases. METHODS An economic evaluation of five different WMPs: 1) low intensity (WMP1); 2) very low calorie diets (VLCD) added to WMP1; 3) moderate intensity (WMP2); 4) high intensity (Look AHEAD); and 5) Roux-en-Y gastric bypass (RYGB) surgery, all compared to a baseline scenario representing no WMP. We also compare a VLCD added to WMP1 vs. WMP1 alone. A microsimulation decision analysis model was used to extrapolate the impact of changes in BMI, obtained from a systematic review and meta-analysis of randomised controlled trials (RCTs) of WMPs and bariatric surgery, on long-term risks of obesity related disease, costs, quality adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs) measured as incremental cost per QALY gained over a 30-year time horizon from a UK National Health Service (NHS) perspective. Sensitivity analyses explored the impact of long-term weight regain assumptions on results. RESULTS RYGB was the most costly intervention but also generated the lowest incidence of obesity related disease and hence the highest QALY gains. Base case ICERs for WMP1, a VLCD added to WMP1, WMP2, Look AHEAD, and RYGB compared to no WMP were £557, £6628, £1540, £23,725 and £10,126 per QALY gained respectively. Adding a VLCD to WMP1 generated an ICER of over £121,000 per QALY compared to WMP1 alone. Sensitivity analysis found that all ICERs were sensitive to the modelled base case, five year post intervention cessation, weight regain assumption. CONCLUSIONS RYGB surgery was the most effective and cost-effective use of scarce NHS funding resources. However, where fixed healthcare budgets or patient preferences exclude surgery as an option, a standard 12 week behavioural WMP (WMP1) was the next most cost-effective intervention.
Collapse
Affiliation(s)
- D Boyers
- Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.
| | | | - E Jacobsen
- Health Economics Research Unit, University of Aberdeen, Aberdeen, UK
| | - A Avenell
- Health Services Research Unit, University of Aberdeen, Aberdeen, UK
| | - P Aveyard
- Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK
- NIHR Oxford Biomedical Research Centre (BRC) Obesity, Diet and Lifestyle Theme, Oxford, UK
- NIHR Applied Research Collaboration (ARC) Oxford and Thames Valley, Oxford, UK
| | | | | | - D Cooper
- Health Services Research Unit, University of Aberdeen, Aberdeen, UK
| | - C Robertson
- Health Services Research Unit, University of Aberdeen, Aberdeen, UK
| | - M Aceves-Martins
- Health Services Research Unit, University of Aberdeen, Aberdeen, UK
| | - B Xu
- UK Health Forum, London, UK
| | - Z Skea
- Health Services Research Unit, University of Aberdeen, Aberdeen, UK
| | - M de Bruin
- Health Psychology, University of Aberdeen, Aberdeen, UK
- Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
| |
Collapse
|
3
|
Abramson JS, Bengston EM, Redd R, Barnes JA, Takvorian T, Sokol L, Lansigan F, Armand P, Shah B, Jacobsen E, Martignetti R, Turba E, Metzler SR, Patterson V, LaCasce AS, Bello CM. MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON‐BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.110_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- J. S. Abramson
- Massachusetts General Hospital Center for Lymphoma Boston Massachusetts USA
| | - E. M. Bengston
- Dartmouth‐Hitchcock Medical Center Hematology/Oncology Lebanon New Hampshire USA
| | - R. Redd
- Dana‐Farber Cancer Institute Biostatistics Boston Massachusetts USA
| | - J. A. Barnes
- Massachusetts General Hospital Center for Lymphoma Boston Massachusetts USA
| | - T. Takvorian
- Massachusetts General Hospital Center for Lymphoma Boston Massachusetts USA
| | - L. Sokol
- Moffitt Cancer Center Hematology/Oncology Tampa USA
| | - F. Lansigan
- Dartmouth‐Hitchcock Medical Center Hematology/Oncology Lebanon New Hampshire USA
| | - P. Armand
- Dana‐Farber Cancer Institute Medical Oncology Boston USA
| | - B. Shah
- Moffitt Cancer Center Hematology/Oncology Tampa USA
| | - E. Jacobsen
- Dana‐Farber Cancer Institute Medical Oncology Boston USA
| | - R. Martignetti
- Massachusetts General Hospital Center for Lymphoma Boston Massachusetts USA
| | - E. Turba
- Moffitt Cancer Center Hematology/Oncology Tampa USA
| | - S. R. Metzler
- Dartmouth‐Hitchcock Medical Center Hematology/Oncology Lebanon New Hampshire USA
| | - V. Patterson
- Dana‐Farber Cancer Institute Medical Oncology Boston USA
| | - A. S. LaCasce
- Dana‐Farber Cancer Institute Medical Oncology Boston USA
| | - C. M. Bello
- Moffitt Cancer Center Hematology/Oncology Tampa USA
| |
Collapse
|
4
|
Wang M, Rule S, Zinzani PL, Goy A, Casasnovas O, Smith SD, Damaj G, Doorduijn JK, Lamy T, Morschhauser F, Panizo C, Shah B, Davies A, Eek R, Dupuis J, Jacobsen E, Kater AP, Gouill S, Oberic L, Robak T, Jain P, Calvo R, Tao L, Dlugosz‐Danecka M. ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.58_2880] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Wang
- MD Anderson Cancer Center, University of Texas Lymphoma ‐ Myeloma, Division of Cancer Medicine Houston Texas USA
| | - S. Rule
- Plymouth University Medical School Hematology Plymouth UK
| | - P. L. Zinzani
- Institute of Hematology “Seràgnoli” University of Bologna Experimental, Diagnostic and Specialty Medicine ‐ DIMES Bologna Italy
| | - A. Goy
- John Theurer Cancer Center, Hackensack University Medical Center Oncology Hackensack New Jersey USA
| | - O. Casasnovas
- CHU Dijon ‐ Hôpital d’Enfants Hematology Dijon France
| | - S. D. Smith
- Fred Hutchinson Cancer Research Center, University of Washington Medical Oncology Seattle Washington USA
| | - G. Damaj
- Institut d’Hématologie de Basse‐Normandie Hematology Caen France
| | - J. K. Doorduijn
- Erasmus MC, HOVON Lunenburg Lymphoma Phase I/II Consortium Hematology Rotterdam Netherlands
| | - T. Lamy
- CHU de Rennes Hematology Rennes France
| | - F. Morschhauser
- CHU Lille, ULR 7365 ‐ GRITA ‐ Groupe de Recherche sur les formes Injectables et les Technologies Associées Hematology Lille France
| | - C. Panizo
- Clínica Universidad de Navarra Hematology Pamplona Spain
| | - B. Shah
- Moffitt Cancer Center Malignant Hematology Tampa Florida USA
| | - A. Davies
- Cancer Research UK Experimental Cancer Medicines Centre, University of Southampton Faculty of Medicine Medical Oncology Southampton UK
| | - R. Eek
- Border Medical Oncology Medical Oncology Albury Australia
| | - J. Dupuis
- Unité Hémopathies Lymphoïdes AP‐HP Hôpital Henri Mondor, Hematology Créteil France
| | - E. Jacobsen
- Dana Farber Cancer Institute Harvard Medical School, Medical Oncology Boston Massachusetts USA
| | - A. P. Kater
- Amsterdam University Medical Center Amsterdam, on behalf of Hovon, Hematology, Lymphoma and Myeloma Research Amsterdam Netherlands
| | - S. Gouill
- CHU de Nantes—Hotel Dieu Hematology Nantes France
| | - L. Oberic
- Institut Universitaire du Cancer—Oncopole Toulouse (IUCT‐O) Hematology Toulouse France
| | - T. Robak
- Copernicus Memorial Hospital, Medical University of Lodz Hematology Lodz Poland
| | - P. Jain
- MD Anderson Cancer Center, University of Texas Leukemia Houston Texas USA
| | - R. Calvo
- AstraZeneca, Clinical Development Hematology R&D Oncology Gaithersburg Maryland USA
| | - L. Tao
- AstraZeneca Biostatistics South San Francisco California USA
| | - M. Dlugosz‐Danecka
- Maria Sklodowska‐Curie National Research Institute of Oncology Hematology Krakow Poland
| |
Collapse
|
5
|
Bagot M, Kim Y, Zinzani PL, Dalle S, Beylot‐barry M, Ortiz‐Romero PL, Cambalia A, Dereure O, Mortier L, Jacobsen E, Rotolo F, Azim HA, Porcu P. LACUTAMAB IN PATIENTS (PTS) WITH ADVANCED MYCOSIS FUNGOIDES (MF) ACCORDING TO KIR3DL2 EXPRESSION: EARLY RESULTS FROM THE TELLOMAK PHASE 2 TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.54_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- M. Bagot
- Hopital St Louis Dermatology Paris France
| | - Y. Kim
- Stanford Cancer Center Dermatology San Francisco USA
| | - P. L. Zinzani
- Policlinico S Orsola‐Malpighi Oncology Hematology Bologna Italy
| | - S. Dalle
- Hospices Civils de Lyon Dermatology Lyon France
| | - M. Beylot‐barry
- Centre Hospitalier Universitaire de Bordeaux ‐ Hôpital Saint‐Andre Dermatology Bordeaux France
| | | | - A. Cambalia
- Hospital Clínic de Barcelona Dermatology Barcelona Spain
| | - O. Dereure
- CHU Montpellier Dermatology Montpellier France
| | - L. Mortier
- CHRU de Lille ‐ Hôpital Claude Huriez Dermatology Lille France
| | - E. Jacobsen
- Dana‐Farber Cancer Institute Oncology Hematology Boston USA
| | - F. Rotolo
- Innate Pharma Clinical Affaires Marseille France
| | - H. A Azim
- Innate Pharma Clinical Development Marseille France
| | - P. Porcu
- Thomas Jefferson University Hematology Oncology Philadelphia USA
| |
Collapse
|
6
|
Bui A, Canales AL, Jacobsen E, LeBoeuf N. 444 Cutaneous langerhans cell histiocytosis in adults: Clinical features, disease course, and management among patients treated at the Dana-Farber Cancer Institute between 2003-2017. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Nikiforow S, King B, Garrity H, Rosati C, Wood A, Nolan M, Smith S, Powers M, Albert C, Stasko K, Schott D, Kelley M, Sturtevant O, Jacobsen E, Ritz J, Lehmann L. Donor risk factors and recipient clinical impact of positive microbial contamination after bone marrow harvests - a large academic medical center experience. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Witzig T, Sokol L, Kim W, Foss F, Jacobsen E, de la Cruz Vincente F, Caballero D, Advani R, Roncero Vidal J, Marin-Niebla A, Rodriguez Izquierdo A, de Ona Navarrete R, Terol M, Domingo-Domenech E, Rodriguez M, Piris M, Bolognese J, Janes M, Burrows F, Kessler L, Mishra V, Curry R, Kurman M, Scholz C, Gualberto A. TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T-CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.32_2629] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- T. Witzig
- Laboratory Medicine and Pathology; Mayo Clinic; Rochester United States
| | - L. Sokol
- Hematology; H. Lee Moffitt Cancer Center & Research Institute; Tampa FL United States
| | - W. Kim
- Hematology - Oncology; Samsung Medical Center; Seoul Republic of Korea
| | - F. Foss
- Medical Oncology; Yale University School of Medicine; New Haven United States
| | - E. Jacobsen
- Medical Oncology; Dana-Farber Cancer Institute; Boston United States
| | | | - D. Caballero
- Hematology - Oncology; Hospital Universitario de Salamanca; Salamanca Spain
| | - R. Advani
- Medicine - Med/Oncology; Stanford University Medical Center; Palo Alto United States
| | | | - A. Marin-Niebla
- Hematology - Oncology; Vall D'Hebron Institute of Oncology; Barcelona Spain
| | | | | | - M.J. Terol
- Hematology; Hospital Clinico Universitario de Valencia; València Spain
| | | | | | - M.A. Piris
- Pathology; Fundación Jiménez Díaz; Madrid Spain
| | | | - M.R. Janes
- Biology; Wellspring Biosciences, Inc.; San Diego United States
| | - F. Burrows
- Research; Kura Oncology, Inc.; San Diego United States
| | - L. Kessler
- Development; Kura Oncology, Inc.; San Diego United States
| | - V. Mishra
- Development; Kura Oncology, Inc.; San Diego United States
| | - R. Curry
- Development; Kura Oncology, Inc.; Cambridge United States
| | - M. Kurman
- Development; Kura Oncology, Inc.; Cambridge United States
| | - C. Scholz
- Development; Kura Oncology, Inc.; Cambridge United States
| | - A. Gualberto
- Development; Kura Oncology, Inc.; Cambridge United States
| |
Collapse
|
9
|
Jagadeesh D, Horwitz S, Bartlett N, Advani R, Jacobsen E, Duvic M, Gautman A, Rao S, Onsum M, Fanale M, Kim Y. RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B-CELL LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.149_2631] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- D. Jagadeesh
- Hematology and Medical Oncology; Cleveland Clinic; Cleveland United States
| | - S. Horwitz
- Department of Medicine; Lymphoma Service, Memorial Sloan Kettering Cancer Center; New York United States
| | - N.L. Bartlett
- Department of Medicine; Oncology Division, Washington University School of Medicine, Siteman Cancer Center; Saint Louis United States
| | - R. Advani
- Medicine-Med/Oncology; Stanford Cancer Institute; Stanford United States
| | - E. Jacobsen
- Division of Hematologic Malignancies; Dana-Farber Cancer Institute; Boston United States
| | - M. Duvic
- Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston United States
| | - A. Gautman
- Clinical Development; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited; Cambridge United States
| | - S. Rao
- Development; Seattle Genetics, Inc.; Bothell United States
| | - M. Onsum
- Development; Seattle Genetics, Inc.; Bothell United States
| | - M. Fanale
- Development; Seattle Genetics, Inc.; Bothell United States
| | - Y. Kim
- Department of Dermatology; Stanford University School of Medicine; Stanford United States
| |
Collapse
|
10
|
Jacobsen E, Ďuraš J, Ardeshna K, Cherry M, Offner F, Mayer J, Bijou F, Tani M, Musuraca G, Merli M, Marasca R, Weaver D, Lustgarten S, Youssoufian H, Zinzani P. CHARACTERIZATION OF DUVELISIB IN PATIENTS WITH REFRACTORY MARGINAL ZONE LYMPHOMA: DATA FROM THE PHASE 2 DYNAMO TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.70_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- E. Jacobsen
- Department of Medical Oncology; Dana-Farber Cancer Institute; Boston MA United States
| | - J. Ďuraš
- University Hospital Ostrava and Faculty of Medicine; University Hospital Ostrava; Ostrava Czech Republic
| | - K. Ardeshna
- Department of Oncology; University College London Hospitals National Health Service Foundation Trust; London United Kingdom
| | - M. Cherry
- Department of Medical Oncology; Atlantic Health Systems; Morristown NJ United States
| | - F. Offner
- Department of Hematology; University Hospital Ghent; Gent Belgium
| | - J. Mayer
- Department of Internal Medicine; Fakultní Nemocnice Brno; Brno Czech Republic
| | - F. Bijou
- Department of Medical Oncology; Institut Bergonie; Boredeaux France
| | - M. Tani
- Hematology Unit; Santa Maria delle Croci Hospital; Ravenna Italy
| | - G. Musuraca
- Hematology Unit; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori; Meldola Italy
| | - M. Merli
- Department of Hematology; Ospedale di Circolo e Fondazione Macchi; Varese Italy
| | - R. Marasca
- Department of Medical Sciences; Section of Hematology, Università di Modena e Reggio Emilia; Modena Italy
| | - D.T. Weaver
- Medical Affairs; Verastem Oncology; Needham MA United States
| | - S. Lustgarten
- Medical Affairs; Verastem Oncology; Needham MA United States
| | - H. Youssoufian
- Medical Affairs; Verastem Oncology; Needham MA United States
| | - P. Zinzani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| |
Collapse
|
11
|
Horwitz S, Foss F, Porcu P, Moskowitz A, Mehta-Shah N, Jacobsen E, Khodadoust M, Kim Y, Weinstock D, Lustgarten S, Baglio M, Youssoufian H, Brammer J. Duvelisib, an oral dual PI3K-δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T-cell lymphoma: rationale for the phase 2 PRIMO trial. Hematol Oncol 2019. [DOI: 10.1002/hon.33_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S.M. Horwitz
- Memorial Sloan Kettering Cancer Center; New York NY United States
| | - F.M. Foss
- Yale Cancer Center; New Haven CT United States
| | - P. Porcu
- Sidney Kimmel Cancer Center; Thomas Jefferson University; Philadelphia PA United States
| | - A. Moskowitz
- Memorial Sloan Kettering Cancer Center; New York NY United States
| | - N. Mehta-Shah
- Washington University Medical School; St. Louis MO United States
| | - E. Jacobsen
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - M.S. Khodadoust
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - Y.H. Kim
- Stanford Cancer Institute/School of Medicine; Stanford CA United States
| | - D. Weinstock
- Dana-Farber Cancer Institute; Boston MA United States
| | | | - M. Baglio
- Verastem Oncology, Inc; Needham MA United States
| | | | - J. Brammer
- Ohio State University; Columbus OH United States
| |
Collapse
|
12
|
Illidge T, Horwitz S, Iyer S, Bartlett N, Kim W, Tilly H, Belada D, Feldman T, Illés Á, Jacobsen E, Hüttmann A, Zinzani P, O'Connor O, Trepicchio W, Miao H, Rao S, Onsum M, Manley T, Advani R. RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON-2 TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.92_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- T. Illidge
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health; University of Manchester, National Institutes of Health and Research Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital National Health Service Foundation Trust; Manchester United Kingdom
| | - S. Horwitz
- Department of Medicine; Lymphoma Service, Memorial Sloan Kettering Cancer Center; New York United States
| | - S. Iyer
- Department of Lymphoma and Myeloma; Division of Cancer Medicine, MD Anderson Cancer Center; Houston United States
| | - N. Bartlett
- Department of Medicine; Oncology Division, Washington University School of Medicine, Siteman Cancer Center; Saint Louis United States
| | - W. Kim
- Division of Hematology-Oncology; Department of Medicine, Samsung Medical Center; Seoul Republic of Korea
| | - H. Tilly
- Department of Hematology; Centre Henri Becquerel, Université of Rouen Normandie; Rouen France
| | - D. Belada
- 4th Department of Internal Medicine - Haematology; Charles University, Hospital and Faculty of Medicine; Hradec Králové Czech Republic
| | - T. Feldman
- Hematology Division; Hackensack University Medical Center; Hackensack United States
| | - Á. Illés
- Department of Hematology; University of Debrecen, Faculty of Medicine; Debrecen Hungary
| | - E. Jacobsen
- Division of Hematologic Malignancies; Dana-Farber Cancer Institute; Boston United States
| | - A. Hüttmann
- Department of Haematology; Universitatsklinikum Essen; Essen Germany
| | - P. Zinzani
- Institute of Hematology; “Seràgnoli” University of Bologna; Bologna France
| | - O.A. O'Connor
- Department of Medicine; Columbia University Medical Center; New York United States
| | - W. Trepicchio
- Clinical Development; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited; Cambridge United States
| | - H. Miao
- Clinical Development; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited; Cambridge United States
| | - S. Rao
- Development; Seattle Genetics, Inc.; Bothell United States
| | - M. Onsum
- Development; Seattle Genetics, Inc.; Bothell United States
| | - T. Manley
- Development; Seattle Genetics, Inc.; Bothell United States
| | - R. Advani
- Medicine - Med/Oncology; Stanford Cancer Institute; Stanford United States
| |
Collapse
|
13
|
Hughes T, Rosano C, Beer J, Jacobsen E, Ganguli M. INFLUENCE OF COGNITION ON CHANGE IN PHYSICAL AND EVERYDAY FUNCTION AMONG INCIDENT FALLERS: THE MYHAT STUDY. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- T Hughes
- Youngstown State University, Beaver, Pennsylvania, United States
| | - C Rosano
- University of Pittsburgh, Pittsburgh, PA
| | - J Beer
- University of Pittsburgh, Pittsburgh, PA, USA
| | - E Jacobsen
- University of Pittsburgh, Pittsburgh, PA, USA
| | - M Ganguli
- University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|
14
|
Payton M, Pinchasik D, Mehta A, Goel S, Zain J, Sokol L, Jacobsen E, Patel M, Horwitz S, Meric-Bernstam F, Shustov A, Weinstock D, Aivado M, Annis D. Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx373.045] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Zinzani P, Wagner-Johnston N, Miller C, Ardeshna K, Tertreault S, Assouline S, Mayer J, Passamonti F, Lunin S, Pettitt A, Nagy Z, Tournilhac O, Abou-Nassar K, Crump M, Jacobsen E, De Vos S, Youssoufian H, Porter J, Prado S, Flinn I. DYNAMO: a PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_57] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- P. Zinzani
- Institute of Hematology Serágnoli; University of Bologna; Bologna Italy
| | | | - C. Miller
- Cancer Institute; St. Agnes Hospital; Baltimore USA
| | - K. Ardeshna
- Cancer Center; University College London; London UK
| | - S. Tertreault
- Department of Hematology; Florida Cancer Specialists Tallahassee; Tallahassee USA
| | - S. Assouline
- Division of Hematology; Jewish General Hospital; Montreal Canada
| | - J. Mayer
- Interni hematologicka; Onkologicka klinika-FN Brno; Brno Czech Republic
| | - F. Passamonti
- Oncology; Ospedale Di Circolo e Fondazione Macchi U.O. Ematologia; Varese Italy
| | - S. Lunin
- Hematology/Oncology; Florida Cancer Specialist Sarasotta; Sarasotta USA
| | - A. Pettitt
- Department of Molecular and Clinical Cancer Medicine, North West Cancer Research Centre; University of Liverpool; Liverpool UK
| | - Z. Nagy
- Belgyogyaszati Klinika; Semmelweis Egyetem, I. sz; Budapest Hungary
| | - O. Tournilhac
- Service d'hématologie; CHU Estaing; Clermont-Ferrand France
| | - K. Abou-Nassar
- Hematology; Centre intégré de santé et de services sociaux de l'Outaouais; Gatineau Canada
| | - M. Crump
- Hematology; Princess Margaret Cancer Center; Toronto Canada
| | - E. Jacobsen
- Hematology and Oncology; Beth Israel Deaconess Medical Center; Boston USA
| | - S. De Vos
- Hematology and Oncology; Ronald Reagan UCLA Medical Center; Los Angeles USA
| | | | - J. Porter
- Clinical Development; Verastem Inc.; Needham USA
| | - S. Prado
- Clinical Development; Verastem Inc.; Needham USA
| | - I. Flinn
- Hematology and Oncology; Sarah Cannon Research Institute; Nashville USA
| |
Collapse
|
16
|
Witzig T, Sokol L, Jacobsen E, Advani R, Mondejar R, Piris M, Burrows F, Melvin C, Mishra V, Scholz C, Gualberto A. PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_115] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- T. Witzig
- Laboratory Medicine and Pathology; Mayo Clinic; Rochester USA
| | - L. Sokol
- Medical Oncology; H. Lee Moffitt Cancer Center & Research Institute; Tampa USA
| | - E. Jacobsen
- Medical Oncology; Dana Farber Cancer Institute; Boston USA
| | - R. Advani
- Medicine - Med/Oncology; Stanford Cancer Institute; Palo Alto USA
| | - R. Mondejar
- Laboratorio de Genómica del Cáncer, IDIVAL-Instituto de Investigación Marqués de Valdecilla; Santander Spain
| | - M. Piris
- Pathology Service, Fundación Jiménez Díaz; Madrid Spain
| | - F. Burrows
- Research & Development; Kura Oncology; La Jolla USA
| | - C. Melvin
- Research & Development; Kura Oncology; La Jolla USA
| | - V. Mishra
- Research & Development; Kura Oncology; La Jolla USA
| | - C. Scholz
- Research & Development; Kura Oncology; La Jolla USA
| | - A. Gualberto
- Research & Development; Kura Oncology; La Jolla USA
| |
Collapse
|
17
|
Abstract
Posttraumatic osteolysis (PO) of the os pubis is a diagnostic entity characterized at radiography by rapidly progressing destructive changes in fractures of the pubic body or rami. Fourteen patients with PO are here reported of whom in 8 the radiographic course of the condition was followed. They were all post-menopausal women and 7 were predisposed to osteopenia. The primary fractures were related to mild trauma in 7 patients and 7 had insufficiency fractures. Four patients had bilateral symmetrical PO. All 14 patients had concomitant insufficiency fractures of the sacrum observed at radiography, CT, scintigraphy or MR, probably due to pelvic instability caused by the PO of the os pubis. Symptoms of the sacral fractures usually dominated the clinical condition. Bony healing of the PO did not occur in any of the patients, but in all 8 patients followed radiographically, the fractures of the sacrum healed clinically and at CT. Knowledge about the condition is important to avoid unnecessary biopsy of the PO considered a metastatic lesion and/or extensive diagnostic search for a primary tumor.
Collapse
|
18
|
Schulz R, Thomas E, Popple R, Fiveash J, Jacobsen E. SU-F-E-07: Web-Based Training for Radiosurgery: Methods and Metrics for Global Reach. Med Phys 2016. [DOI: 10.1118/1.4955693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
19
|
Grave K, Torren-Edo J, Muller A, Greko C, Moulin G, Mackay D, Fuchs K, Laurier L, Iliev D, Pokludova L, Genakritis M, Jacobsen E, Kurvits K, Kivilahti-Mantyla K, Wallmann J, Kovacs J, Lenharthsson JM, Beechinor JG, Perrella A, Mi ule G, Zymantaite U, Meijering A, Prokopiak D, Ponte MH, Svetlin A, Hederova J, Madero CM, Girma K, Eckford S. Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries. J Antimicrob Chemother 2014; 69:2284-91. [DOI: 10.1093/jac/dku106] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Abstract
Abstract
Plant breeding is a multidisciplinary scientific activity with tool development as driving force. It is clear from history that availability of genetic variation and selection methods are bottom lines for variety development. The genetic source of traditional plant breeding is restricted to domestication of traits from the so-called 'breeders' gene pool', consisting of crossable sources. Gene cloning and genetic transformation broaden the available genetic variation to genes from all living organisms. The so-called new genes in genetically modified organism (GMO) plants, consist of transgenes, with (chimaeric) genes from outside the 'breeder's gene pool'. Transgenic plants needed additional biosafety rules such as Directive 2001/18EC. However, these are not needed after transformation of the four rol-genes from wild-type Agrobacterium rhizogenes. In the meantime, cloned cisgenes, natural dominant genes from 'breeders' gene pool', are available, enabling cisgenic crops after marker-free transformation, which extends plant breeding with traditional traits. From long-term experience, it is clear that traditional breeding with the 'breeders' gene pool' has a history of safe use. Different scientific committees concluded that cisgenic crops are as safe as traditionally bred varieties. So, cisgenesis is a powerful new tool for plant breeding with traditional traits as indicated in the potential examples on: (1) breeding for durable resistance to potato late blight and apple scab by R-gene stacking; (2) the new possibility to come to stacking of monogenic resistance alleles in wheat; (3) engineering of restoration of cytoplasmic male sterility by cloned restorer genes and of altering gametophytic incompatibility by introducing additional S-alleles; (4) increasing phytase activity by gene dosage effect in barley; and (5) the possibility of changing hormone metabolism in (fruit) trees leading to important morphological alterations. In near future, because of availability of many more cisgenes, it is expected that the possibilities of cisgenesis will increase rapidly as the next step in plant breeding with traditional traits, if treatment as non-GMO is approved.
Collapse
|
21
|
Li Y, van der Lee TAJ, Evenhuis A, van den Bosch GBM, van Bekkum PJ, Förch MG, van Gent-Pelzer MPE, van Raaij HMG, Jacobsen E, Huang SW, Govers F, Vleeshouwers VGAA, Kessel GJT. Population dynamics of Phytophthora infestans in the Netherlands reveals expansion and spread of dominant clonal lineages and virulence in sexual offspring. G3 (Bethesda) 2012; 2:1529-40. [PMID: 23275876 PMCID: PMC3516475 DOI: 10.1534/g3.112.004150] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/28/2012] [Accepted: 09/22/2012] [Indexed: 11/18/2022]
Abstract
For a comprehensive survey of the structure and dynamics of the Dutch Phytophthora infestans population, 652 P. infestans isolates were collected from commercial potato fields in the Netherlands during the 10-year period 2000-2009. Genotyping was performed using 12 highly informative microsatellite markers and mitochondrial haplotypes. In addition, for each isolate, the mating type was determined. STRUCTURE analysis grouped the 322 identified genotypes in three clusters. Cluster 1 consists of a single clonal lineage NL-001, known as "Blue_13"; all isolates in this cluster have the A2 mating type and the Ia mitochondrial haplotype. Clusters 2 and 3 display a more elaborate substructure containing many unique genotypes. In Cluster 3, several distinct clonal lineages were also identified. This survey witnesses that the Dutch population underwent dramatic changes in the 10 years under study. The most notable change was the emergence and spread of A2 mating type strain NL-001 (or "Blue_13"). The results emphasize the importance of the sexual cycle in generating genetic diversity and the importance of the asexual cycle as the propagation and dispersal mechanism for successful genotypes. Isolates were also screened for absence of the Avrblb1/ipiO class I gene, which is indicative for virulence on Rpi-blb1. This is also the first report of Rpi-blb1 breakers in the Netherlands. Superimposing the virulence screening on the SSR genetic backbone indicates that lack the Avrblb1/ipiO class I gene only occurred in sexual progeny. So far, the asexual spread of the virulent isolates identified has been limited.
Collapse
Affiliation(s)
- Y. Li
- Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, 100081, Beijing, China
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - T. A. J. van der Lee
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - A. Evenhuis
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - G. B. M. van den Bosch
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - P. J. van Bekkum
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - M. G. Förch
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - M. P. E van Gent-Pelzer
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - H. M. G. van Raaij
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| | - E. Jacobsen
- Laboratory of Plant Breeding, Wageningen University, 6708 PB Wageningen, The Netherlands
| | - S. W. Huang
- Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, 100081, Beijing, China
| | - F. Govers
- Laboratory of Phytopathology, Wageningen University, 6700 EE Wageningen, The Netherlands
- Centre for BioSystems Biology, 6700 AB Wageningen, The Netherlands
| | | | - G. J. T. Kessel
- Bio-interactions and Plant Health, Plant Research International, 6700 AA Wageningen, The Netherlands
| |
Collapse
|
22
|
Shaughnessy P, Uberti J, Devine S, Maziarz RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, Ball ED, Berryman R, Dugan M, Joyce R, Hsu FJ, Johns D, McSweeney P. Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program. Bone Marrow Transplant 2012. [DOI: 10.1038/bmt.2012.219] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
23
|
El-Kharbotly A, Jacobs JM, Hekkert BT, Stiekema WJ, Pereira A, Jacobsen E, Ramanna MS. Localization of Ds-transposon containing T-DNA inserts in the diploid transgenic potato: linkage to the R1 resistance gene against Phytophthora infestans (Mont.) de Bary. Genome 2012; 39:249-57. [PMID: 18469890 DOI: 10.1139/g96-034] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The Dissociation transposable element (Ds) of maize containing NPTII was introduced into the diploid potato (Solanum tuberosum) clone J91-6400-A16 through Agrobacterium tumefaciens mediated transformation. Genomic DNA sequences flanking the T-DNAs from 312 transformants were obtained with inverse polymerase chain reaction or plasmid rescue techniques and used as probes for RFLP linkage analysis. The RFLP map location of 60 T-DNAs carrying Ds-NPTII was determined. The T-DNA distribution per chromosome and the relative distance between them appeared to be random. All 12 chromosomes have been covered with Ds-containing T-DNAs, potentially enabling tagging of any gene in the potato genome. The T-DNA insertions of two transformants, BET92-Ds-A16-259 and BET92-Ds-A16-416, were linked in repulsion to the position of the resistance gene R1 against Phytophthora infestans. After crossing BET92-Ds-A16-416 with a susceptible parent, 4 desired recombinants (Ds carrying T-DNA linked in coupling phase with the R1 gene) were discovered. These will be used for tagging the R1 gene. The efficiency of the pathway from the introduction to localization of T-DNAs is discussed. Key words : Solanum tuberosum, Phytophthora infestans, Ds element, transposon tagging, R genes, euchromatin.
Collapse
|
24
|
|
25
|
Dalton SO, Frederiksen BL, Jacobsen E, Steding-Jessen M, Østerlind K, Schüz J, Osler M, Johansen C. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008. Br J Cancer 2011; 105:1042-8. [PMID: 21897390 PMCID: PMC3185954 DOI: 10.1038/bjc.2011.342] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Introduction: We investigated the association between socioeconomic position, stage at diagnosis, and length of period between referral and diagnosis in a nationwide cohort of lung cancer patients. Methods: Through the Danish Lung Cancer Register, we identified 18 103 persons diagnosed with lung cancer (small cell and non-small cell) in Denmark, 2001–2008, and obtained information on socioeconomic position and comorbidity from nationwide administrative registries. The odds ratio (OR) for a diagnosis of advanced-stage lung cancer (stages IIIB–IV) and for a diagnosis >28 days after referral were analysed by multivariate logistic regression models. Results: The adjusted OR for advanced-stage lung cancer was reduced among persons with higher education (OR, 0.92; 95% confidence interval (CI), 0.84–0.99), was increased in persons living alone (OR, 1.06; 95% CI, 1.01–1.13) and decreased stepwise with increasing comorbidity. Higher education was associated with a reduced OR for >28 days between referral and diagnosis as was high income in early-stage patients. Male gender, age and severe comorbidity were associated with increased ORs in advanced-stage patients. Interpretation: Differences by socioeconomic position in stage at diagnosis and in the period between referral and diagnosis indicate that vulnerable patients presenting with lung cancer symptoms require special attention.
Collapse
Affiliation(s)
- S O Dalton
- Department of Psychosocial Cancer Research, Institute of Cancer Epidemiology, Danish Cancer Society, 49 Strandboulevarden, 2100 Copenhagen, Denmark.
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Kortstee AJ, Khan SA, Helderman C, Trindade LM, Wu Y, Visser RGF, Brendolise C, Allan A, Schouten HJ, Jacobsen E. Anthocyanin production as a potential visual selection marker during plant transformation. Transgenic Res 2011; 20:1253-64. [PMID: 21340526 PMCID: PMC3210953 DOI: 10.1007/s11248-011-9490-1] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2010] [Accepted: 02/03/2011] [Indexed: 11/24/2022]
Abstract
A mutant allele of the transcription factor gene MYB10 from apple induces anthocyanin production throughout the plant. This gene, including its upstream promoter, gene coding region and terminator sequence, was introduced into apple, strawberry and potato plants to determine whether it could be used as a visible selectable marker for plant transformation as an alternative to chemically selectable markers, such as kanamycin resistance. After transformation, red coloured calli, red shoots and red well-growing plants were scored. Red and green shoots were harvested from apple explants and examined for the presence of the MYB10 gene by PCR analysis. Red shoots of apple explants always contained the MYB10 gene but not all MYB10 containing shoots were red. Strawberry plants transformed with the MYB10 gene showed anthocyanin accumulation in leaves and roots. No visible accumulation of anthocyanin could be observed in potato plants grown in vitro, even the ones carrying the MYB10 gene. However, acid methanol extracts of potato shoots or roots carrying the MYB10 gene contained up to four times higher anthocyanin content than control plants. Therefore anthocyanin production as result of the apple MYB10 gene can be used as a selectable marker for apple, strawberry and potato transformation, replacing kanamycin resistance.
Collapse
Affiliation(s)
- A J Kortstee
- Wageningen UR Plant Breeding, Wageningen University and Research Centre, P.O. Box 386, 6700 AJ Wageningen, The Netherlands.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Bishop F, Jacobsen E, Shaw J, Kaptchuk T. Debriefing to placebo allocation: A phenomenological study of participants’ experiences in a randomized clinical trial. Eur J Integr Med 2010. [DOI: 10.1016/j.eujim.2010.09.058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Joshi S, Soriano J, Kortstee A, Schaart J, Krens F, Jacobsen E, Schouten H. DEVELOPMENT OF CISGENIC APPLES WITH DURABLE RESISTANCE TO APPLE SCAB. ACTA ACUST UNITED AC 2009. [DOI: 10.17660/actahortic.2009.839.53] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Wilhjelm BJ, Jacobsen E. The protective action of different barbituric acid derivatives against anoxia in mice. Acta Pharmacol Toxicol (Copenh) 2009; 28:203-8. [PMID: 5468074 DOI: 10.1111/j.1600-0773.1970.tb00545.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
30
|
Jacobsen E. Knud O. Moller, June 21, 1896--August 23, 1973. Acta Pharmacol Toxicol (Copenh) 2009; 33:321-5. [PMID: 4588637 DOI: 10.1111/j.1600-0773.1973.tb01533.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
31
|
Abstract
The metabolism of cyclophosphamide was determined in five patients with severe renal insufficiency. After the intravenous injection of 14-C-cyclophosphamide the activities due to unchanged cyclophosphamide and metabolites were determined in samples from urine and serum for 2-3 days. Only 22% of the injected radioactivity could be recovered in the urine during the first 3 days as against the normal of some 65% The rate of biotransformation seemed normal and in agreement with these findings a very long term retention of metabolites could be demonstrated. The clinical implications of these results are discussed.
Collapse
|
32
|
Schenk MF, Fischer AR, Frewer LJ, Gilissen LJ, Jacobsen E, Smulders MJ. The influence of perceived benefits on acceptance of GM applications for allergy prevention. Health, Risk & Society 2008. [DOI: 10.1080/13698570802160947] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Ratain MJ, Napoli KL, Moshier K, Jiang X, Fleming GF, Gajewski TF, Jacobsen E, Cohen EE. A phase 1b study of oral rapamycin (sirolimus) in patients with advanced malignancies. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.3510] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3510 Background: Rapamycin (R) analogues are being studied as cancer therapies since mTOR is recognized as a relevant target in several cancer types. However, R is readily available, has been well-studied in organ transplant patients, was the first recognized mTOR inhibitor, and demonstrates efficacy in preclinical cancer models. The aims of this study were to define R’s maximum tolerated dose (MTD), observed toxicities, dose-limiting toxicities (DLT), pharmacokinetics and effect on inhibition of phosphorylation of p70 S6 kinase (S6K) in peripheral T-cells (PTL). Methods: R was administered orally once weekly to successive cohorts of patients using an adaptive escalation design based on whole blood concentrations ([R]), using a validated HPLC procedure. S6K was assessed by stimulating CD3+ cells ex-vivo with PMA and ionomycin for 1 hour, followed by Western blot analysis using antibodies directed against phospho-Thr389 of S6K versus total S6K as a loading control. Results: 24 subjects have been enrolled in dose cohorts of 10 mg, 20 mg, 30 mg, and 60 mg. The mean [R] observed on day 2 of week 1 (24 hr after 1st dose) was 5.5±2.7, 11.6±6.0 and 22.6±10.7 ng/mL, for dose levels 10 mg, 20 mg and 30 mg, respectively. [R] decreased by ∼50% by day 4 of week 1 (2.7±1.0, 6.9±4.0 and 11.0±7.7 ng/mL, respectively). By day 1 of week 2 (prior to the next dose of R), [R] had decreased below the limit of quantitation (2 ng/mL) for all subjects at 10 mg, 3 of 7 at 20 mg, and 4 of 6 at 30 mg. Preliminary analysis suggests that sustained phospho-S6K inhibition was achieved in some patients at 30 mg. The most common toxicities observed included nausea (50%), diarrhea (42%), asthenia (38%), hyperglycemia (58%), anemia (46%), and lymphopenia (33%). DLTs observed include 1 patient with grade 3 pneumonia at 20 mg, 1 patient with grade 3 dehydration at 30 mg, and 1 patient with grade 3 asthenia at 60 mg. Stable disease has been observed in 46% of evaluable patients. Conclusions: R can be feasibly administered orally on a once weekly schedule with a similar toxicity and pharmacokinetic profile compared with other mTOR inhibitors. Preliminary evidence suggests that prolonged suppression of phospho-S6K in PTL is possible at well-tolerated doses. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. J. Ratain
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - K. L. Napoli
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - K.Knightley Moshier
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - X. Jiang
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - G. F. Fleming
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - T. F. Gajewski
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - E. Jacobsen
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| | - E. E. Cohen
- University of Chicago, Chicago, IL; University of Texas Medical School at Houston, Houston, TX
| |
Collapse
|
34
|
O'Neill K, Protheroe C, Ochkur S, Jacobsen E, Colbert D, Rinaldi L, Irvin C, McGarry M, Lee J, Lee N. A Causative Link Exists Between Eosinophil Major Basic Protein-2 and Allergen-Induced Airway Hyperresponsiveness. J Allergy Clin Immunol 2007. [DOI: 10.1016/j.jaci.2006.11.530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
35
|
Ochkur S, Biechele T, Jacobsen E, McElhinney B, Protheroe C, Pero R, Borchers M, O'Neill K, Colbert D, McGarry M, Janssen-Heininger Y, Irvin C, Shen H, Lee J, Lee N. Co-Expression of IL-5 and Eotaxin-2 in Mice Creates a Novel and Eosinophil-dependent Pulmonary Model of Respiratory Inflammation Characteristic of Human Disease. J Allergy Clin Immunol 2007. [DOI: 10.1016/j.jaci.2006.11.529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Affiliation(s)
- E Jacobsen
- Biological Laboratories of Medicinalco Ltd., Copenhagen
| |
Collapse
|
37
|
Jacobsen E, Van Den Abbeele AD, Neuberg D, Li S, Fisher DC, Friedberg J, Barnes AS, Yap JT, Kutok J, Freedman AS. Inhibiting TNFα with etanercept in relapsed/refractory follicular lymphoma. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.17525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
17525 Background: Follicular dendritic cells (FDC) support the survival of follicular lymphoma (FL). TNFα is overexpressed by FL cells and TNFα plays a central role in the development and maintenance of normal FDCs. TNFα may be an ideal target for therapy due to its pleotropic effects on FDCs. Inhibition of TNFα is possible with the decoy receptor, etanercept. Methods: Patients with relapsed/refractory FL received 8 weeks of etanercept, 25 mg SC on day 1 and 4 of each week. Patients with any response or stable disease (SD) received 16 more weeks of etanercept at the same dose/schedule. 7 patients enrolled from April 2002 to September 2005. Median age was 63. All patients had stage III/IV disease and had received multiple chemotherapy regimens (median 3); 2 had prior autologous stem cell transplant. FDG-PET was performed at baseline and after 8 (scan 1, n = 7 patients) and 24 weeks on therapy (scan 2, n = 3 patients). Maximum standardized uptake values (SUVmax) were measured in up to 3 lesions per patient (n = 17 lesions for scan 1; 7 lesions for scan 2). The summation SUVmax of all lesions was calculated at each time point. The percentage (%) change in SUVmax in individual lesions and the summed SUVmax for each patient was calculated relative to baseline. The % metabolic response (mR) was assessed using EORTC thresholds for % SUVmax change (mPR ≤ −25% < mSD < +25% ≤ PD). Results: All patients completed at least 8 weeks of etanercept. 2 patients completed 24 weeks. 5 patients had minor or mixed responses. At the 8 week evaluation 5 patients had SD and 2 had progressive disease (PD). Of the 5 with SD, 2 progressed at 9 and 12 weeks of therapy and 3 progressed by 24 weeks. PET scan 1 showed mPR in 5/7 pts, SD in 2/7 and no PD. PET scan 2 showed mPR in 2/3 pts, mSD in 1/3 and no mPD.All patients are alive at a median of 20+ months after therapy. 1 grade 3 toxicity (lymphopenia) and 3 grade 1/2 toxicities (rhinitis/URI and 2 injection site reactions) were reported. Conclusions: Etanercept was well tolerated and minor clinical responses were observed. By EORTC criteria for metabolic response, mPR occurred in 5/7 pts, mSD in 2/7 and there was no mPD. The significant number of metabolic PR’s suggest that targeting the microenvironment with agents like etanercept may be a novel treatment approach for FL. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- E. Jacobsen
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - A. D. Van Den Abbeele
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - D. Neuberg
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - S. Li
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - D. C. Fisher
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - J. Friedberg
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - A. S. Barnes
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - J. T. Yap
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - J. Kutok
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| | - A. S. Freedman
- Dana-Farber Cancer Institute, Boston, MA; University of Rochester, Rochester, NY; Brigham and Women’s Hospital, Boston, MA
| |
Collapse
|
38
|
Supena EDJ, Suharsono S, Jacobsen E, Custers JBM. Successful development of a shed-microspore culture protocol for doubled haploid production in Indonesian hot pepper (Capsicum annuum L.). Plant Cell Rep 2006; 25:1-10. [PMID: 16172897 DOI: 10.1007/s00299-005-0028-y] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/01/2004] [Revised: 10/28/2004] [Accepted: 05/19/2005] [Indexed: 05/04/2023]
Abstract
Various systems of anther and microspore cultures were studied to establish an efficient doubled haploid production method for Indonesian hot pepper (Capsicum annuum L.). A shed-microspore culture protocol was developed which outperformed all the previously reported methods of haploid production in pepper. The critical factors of the protocol are: selection of flower buds with more than 50% late unicellular microspores, a 1 day 4 degrees C pretreatment of the buds, followed by culture of the anthers in double-layer medium system for 1 week at 9 degrees C and thereafter at 28 degrees C in continuous darkness. The medium contained Nitsch components and 2% maltose, with 1% activated charcoal in the solid under layer and 2.5 muM zeatin and 5 muM indole-3-acetic acid in the liquid upper layer. All the ten genotypes of hot pepper tested, responded to this protocol. The best genotypes produced four to seven plants per original flower bud. This protocol can be used as a potential tool for producing doubled haploid plants for hot pepper breeding.
Collapse
Affiliation(s)
- E D J Supena
- Research Center for Biotechnology, Bogor Agricultural University (IPB), P.O. Box 1, Bogor 16610, Indonesia
| | | | | | | |
Collapse
|
39
|
Jensen VF, Jacobsen E, Bager F. Veterinary antimicrobial-usage statistics based on standardized measures of dosage. Prev Vet Med 2004; 64:201-15. [PMID: 15325773 DOI: 10.1016/j.prevetmed.2004.04.001] [Citation(s) in RCA: 137] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2002] [Revised: 02/19/2004] [Accepted: 04/06/2004] [Indexed: 10/26/2022]
Abstract
In human medicine, the defined daily dose is used as a technical measure of drug usage, which is independent of the variations in the potency of the active compound and the formulation of the pharmaceutical product--therefore providing a measure of the relative importance of different drugs. A national system of animal defined daily doses (ADD) for each age-group and species has been defined in VetStat (the Danish national system monitoring veterinary therapeutic drug use). The usage is further standardized according to the number of animals in the target population, acquired from production data on the national level or on herd size by species and age in the Danish central husbandry register (CHR). Statistics based on standardized measures of VetStat data can be used for comparison of drug usage between different herds, veterinary practices, or geographic regions (allowing subdivision by animal species and animal production class, route of administration, disease categories, season and geographic location). Individual statistics are available as interactive reports to the control authorities, farmers and veterinary practitioners by a secure access to the database. The ADD also is used in pharmaco-epidemiogical research and to assist in the interpretation of resistance-surveillance data.
Collapse
Affiliation(s)
- V F Jensen
- Department of Epidemiology and Risk Assessment, Danish Institute for Food and Veterinary Research, Mörkhöj Bygade 19, DK-2860 Söborg, Denmark.
| | | | | |
Collapse
|
40
|
Kamstra SA, de Jong JH, Jacobsen E, Ramanna MS, Kuipers AGJ. Meiotic behaviour of individual chromosomes in allotriploid Alstroemeria hybrids. Heredity (Edinb) 2004; 93:15-21. [PMID: 15100711 DOI: 10.1038/sj.hdy.6800465] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Chromosome association and chiasma formation were studied in pollen mother cells at metaphase I of four allotriplod BC1 plants (2n=3x=24) obtained from the backcross of the hybrid Alstroemeria aurea x A. inodora with its parent A. inodora. We distinguished the chromosomes of both parental species by genomic in situ hybridization (GISH), whereas the individual chromosomes were identified on the basis of their multicolour FISH banding patterns obtained after a second hybridization with two species-specific satellite repeats as probes. All the four BC1 plants possessed two genomes of A. inodora and one of A. aurea. Variable numbers of recombinant chromosomes, resulting from meiotic recombination in the interspecific hybrid, were present in these plants. The homologous A. inodora chromosomes generally formed bivalents, leaving the homoeologous A. aurea chromosomes unassociated. High frequencies of trivalents were observed for the chromosome sets that contained recombinant chromosomes, even when the recombinant segments were small. Chromosome associations in the trivalents were restricted to homologous segments. The implications of the absence of homoeologous chromosome pairing on gamete constitution and prospects for introgression in Alstroemeria are discussed.
Collapse
Affiliation(s)
- S A Kamstra
- Laboratory of Plant Breeding, The Graduate School of Experimental Plant Sciences, Wageningen University, PO Box 386, 6700 AJ Wageningen, The Netherlands
| | | | | | | | | |
Collapse
|
41
|
Brandslund I, Jacobsen E, Jacobsen A. S-HER2 by chemiluminescence versus ELISA. EJC Suppl 2004. [DOI: 10.1016/s1359-6349(04)90786-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
42
|
Abstract
The Danish Ministry of Food, Agriculture and Fisheries funds a monitoring system based on drug usage information collected at the herd level: VETSTAT. VETSTAT is constructed as a relational database and data originates from three sources: pharmacies, veterinarians and feed mills. All administration of drugs for use in animal production is reported on a monthly basis. Pharmacies provided 95% of the total weight antimicrobial compounds used in Denmark in 2001. More than 80% of the antimicrobial compounds reported by pharmacies were sold on prescription to end-users (owners) and included information on animal species, age-group and diagnostic grouping; >90% of the total amount of antimicrobials sold on prescription was used for pigs. In 2001, sales of 96,500 kg of antimicrobials were reported.
Collapse
Affiliation(s)
- H Stege
- EpiConsult ApS, B&A, 14 Hørkaer, DK-2730, Herlev, Denmark.
| | | | | | | |
Collapse
|
43
|
Lim KB, Ramanna MS, Jacobsen E, van Tuyl JM. Evaluation of BC2 progenies derived from 3x-2x and 3x-4x crosses of Lilium hybrids: a GISH analysis. Theor Appl Genet 2003; 106:568-574. [PMID: 12589558 DOI: 10.1007/s00122-002-1070-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2002] [Accepted: 06/07/2002] [Indexed: 05/24/2023]
Abstract
An allotriploid (ALA, 2n=3 x=36) BC(1) plant was obtained by backcrossing a diploid F(1) interspecific hybrid (LA, 2n=2 x=24), derived from a Lilium longiflorum (L genome) and an Asiatic hybrid (A genome), to the latter parent. This allotriploid was backcrossed to a diploid Asiatic hybrid (2n=2 x=24) and to an allotetraploid (LLAA, 2n=4 x=48) LA hybrid. A total of 25 plants of these crosses were examined for ploidy level, and 12 individuals were analyzed for their genome constitution through genomic in situ hybridization (GISH). In most cases the progenies from the triploid-diploid (3 x-2 x) crosses consisted of aneuploids. Further more, there was evidence for the formation of near-haploid (x=12+2) to triploid (3 x=36) gametes in the allotriploid BC(1) plant. The progenies of triploid-tetraploid (3 x-4 x) cross also consisted of mostly aneuploids but in this case the triploid female parent had contributed predominantly near-triploid (2n) gametes for the origin of BC(2) progenies. The different ploidy levels observed between 3 x-2 x and 3 x-4 x crosses are possibly caused by preferential fertilization or survival resulting in a different ratio of chromosome numbers between the embryo and endosperm. Though Lilium has a tetrasporic, eight-nucleate type of embryo sac formation (Fritillaria type), the observed difference between the progeny types in 3 x-2 x and 3 x-4 x crosses is comparable to that of observed in monosporic eight nucleate types (Polygonum type) that predominate in most genera of Angiosperms. An important feature of the genome constitution of the progenies was that the homoeologous recombinant chromosomes were transmitted intact from BC(1) to BC(2) progenies in variable numbers. In addition, there was evidence for the occurrence of new homoeologous recombinations in the triploid BC(1). Of the two euploid BC(2) plants one had originated through the parthenogenetic development of a 2n egg and the other had originated through indeterminate meiotic restitution (IMR).
Collapse
Affiliation(s)
- K-B Lim
- National Institute of Agricultural Biotechnology, RDA, Suwon, Korea
| | | | | | | |
Collapse
|
44
|
Visker MHPW, Keizer LCP, Van Eck HJ, Jacobsen E, Colon LT, Struik PC. Can the QTL for late blight resistance on potato chromosome 5 be attributed to foliage maturity type? Theor Appl Genet 2003; 106:317-325. [PMID: 12582858 DOI: 10.1007/s00122-002-1021-2] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2002] [Accepted: 05/08/2002] [Indexed: 05/24/2023]
Abstract
We investigated the association between late blight resistance and foliage maturity type in potato by means of molecular markers. Two QTLs were detected for foliage resistance against Phytophthora infestans (on chromosomes 3 and 5) and one for foliage maturity type (on chromosome 5). The QTL for resistance to late blight and the QTL for foliage maturity type on chromosome 5 appeared to be mapped on indistinguishable positions. We were interested whether this genetic linkage was due to closely linked but different genes, or due to one (or more) gene(s) with pleiotropic effects. We therefore developed an approach to detect QTLs, in which resistance to late blight was adjusted for foliage maturity type. This analysis revealed the same two QTLs for resistance against P. infestans, but the effect of the locus on chromosome 5 was reduced to only half the original effect. This is a strong indication that the two indistinguishable QTLs for foliage maturity type and for late blight resistance on chromosome 5 may actually be one gene with a pleiotropic effect on both traits. However, there was still a significant effect on resistance against P. infestans on the locus on chromosome 5 after adjusting for foliage maturity type. Therefore we cannot rule out the presence of two closely linked QTLs on chromosome 5: one with a pleiotropic effect on both late blight resistance and foliage maturity type, and another with merely an effect on resistance. In addition, the two QTLs for resistance to late blight showed an important epistatic interaction, suggesting that QTLs for resistance affect each other's expression.
Collapse
Affiliation(s)
- M H P W Visker
- Plant Research International, P.O. Box 16, 6700 AA, Wageningen, The Netherlands.
| | | | | | | | | | | |
Collapse
|
45
|
Abstract
RATIONALE AND OBJECTIVES The authors performed this study to compare a declarative memory paradigm developed to help teach medical students about the cranial nerves with a traditional text-based approach. MATERIALS AND METHODS The authors designed a clock-based paradigm to help medical students learn about the cranial nerves. To enhance memorization and related brain activation, the paradigm uses visual, spatial, and word associations in the context of an analog clock face. Twenty-one undergraduate students were randomly divided into two groups. Group T viewed traditional text slides, and group C viewed text slides followed by the corresponding cranial clock slides. Subjects were tested before and after these sessions. RESULTS Group C performed significantly better than group T in learning the names of the cranial nerves and their correct order (P < .011). Recall of name, number, and function was better for 11 of 12 cranial nerves, with statistical significance reached for nerves III (P = .005), V (P = .04), and X (P = .03). CONCLUSION Alternative teaching strategies may help improve declarative memory.
Collapse
Affiliation(s)
- K L Weiss
- Department of Radiology, University of Michigan Medical Center, Ann Arbor 48109-0030, USA
| | | | | | | | | | | |
Collapse
|
46
|
Lim KB, Wennekes J, de Jong JH, Jacobsen E, van Tuyl JM. Karyotype analysis of Lilium longiflorum and Lilium rubellum by chromosome banding and fluorescence in situ hybridisation. Genome 2001; 44:911-8. [PMID: 11681616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
Detailed karyotypes of Lilium longiflorum and L. rubellum were constructed on the basis of chromosome arm lengths, C-banding, AgNO3 staining, and PI-DAPI banding, together with fluorescence in situ hybridisation (FISH) with the 5S and 45S rDNA sequences as probes. The C-banding patterns that were obtained with the standard BSG technique revealed only few minor bands on heterologous positions of the L. longiflorum and L. rubellum chromosomes. FISH of the 5S and 45S rDNA probes on L. longiflorum metaphase complements showed overlapping signals at proximal positions of the short arms of chromosomes 4 and 7, a single 5S rDNA signal on the secondary constriction of chromosome 3, and one 45S rDNA signal adjacent to the 5S rDNA signal on the subdistal part of the long arm of chromosome 3. In L. rubellum, we observed co-localisation of the 5S and 45S rDNA sequences on the short arm of chromosomes 2 and 4 and on the long arms of chromosomes 2 and 3, and two adjacent bands on chromosome 12. Silver staining (Ag-NOR) of the nucleoli and NORs in L. longiflorum and L. rubellum yielded a highly variable number of signals in interphase nuclei and only a few faint silver deposits on the NORs of mitotic metaphase chromosomes. In preparations stained with PI and DAPI, we observed both red- and blue-fluorescing bands at different positions on the L. longiflorum and L. rubellum chromosomes. The red-fluorescing or so-called reverse PI-DAPI bands always coincided with rDNA sites, whereas the blue-fluorescing DAPI bands corresponded to C-bands. Based on these techniques, we could identify most of chromosomes of the L. longiflorum and L. rubellum karyotypes.
Collapse
Affiliation(s)
- K B Lim
- Plant Research International, Business Unit Genetics and Breeding, Wageningen, The Netherlands.
| | | | | | | | | |
Collapse
|
47
|
van de Wal MH, Jacobsen E, Visser RG. Multiple allelism as a control mechanism in metabolic pathways: GBSSI allelic composition affects the activity of granule-bound starch synthase I and starch composition in potato. Mol Genet Genomics 2001; 265:1011-21. [PMID: 11523773 DOI: 10.1007/s004380100496] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Multiple allelism in heterozygous autopolyploid species like potato not only occurs for genes that affect morphological characteristics but also for genes involved in metabolic pathways. Based on a combination of Southern and PCR analyses, at least eight alleles encoding granule-bound starch synthase I (GBSSI), which is responsible for amylose biosynthesis, have been identified in potato. These alleles were grouped into four classes, distinguishable by Southern analysis, and subdivided based on PCR. Despite the heterozygous and polyploid character of potato it was possible to assign variation in GBSSI activity to the allelic composition at the GBSSI loci within a large population of Solanum tuberosum cultivars and Solanum breeding lines. Moreover, the availability of an amf allele made it possible to reduce heterogeneity and enabled us to demonstrate an effect of GBSSI allelic composition on amylose content. The major difference between the alleles identified was the absence or presence of a 140-bp fragment at a site 0.5 kb upstream of the ATG start codon of the gene for GBSSI. The absence of this 140-bp fragment had a major effect on GBSSI activity and amylose content, while the presence of small deletions and simple sequence repeats had no obvious effect.
Collapse
Affiliation(s)
- M H van de Wal
- Laboratory of Plant Breeding, Graduate School Experimental Plant Sciences, Wageningen University, The Netherlands
| | | | | |
Collapse
|
48
|
Zheng SJ, Henken B, Sofiari E, Jacobsen E, Krens FA, Kik C. Molecular characterization of transgenic shallots (Allium cepa L.) by adaptor ligation PCR (AL-PCR) and sequencing of genomic DNA flanking T-DNA borders. Transgenic Res 2001; 10:237-45. [PMID: 11437280 DOI: 10.1023/a:1016633410041] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Genomic DNA blot hybridization is traditionally used to demonstrate that, via genetic transformation, foreign genes are integrated into host genomes. However, in large genome species, such as Allium cepa L., the use of genomic DNA blot hybridization is pushed towards its limits, because a considerable quantity of DNA is needed to obtain enough genome copies for a clear hybridization pattern. Furthermore, genomic DNA blot hybridization is a time-consuming method. Adaptor ligation PCR (AL-PCR) of genomic DNA flanking T-DNA borders does not have these drawbacks and seems to be an adequate alternative to genomic DNA blot hybridization. Using AL-PCR we proved that T-DNA was integrated into the A. cepa genome of three transgenic lines transformed with Agrobacterium tumefaciens EHA 105 (pCAMBIA 1301). The AL-PCR patterns obtained were specific and reproducible for a given transgenic line. The results showed that T-DNA integration took place and gave insight in the number of T-DNA copies present. Comparison of AL-PCR and previously obtained genomic DNA blot hybridization results pointed towards complex T-DNA integration patterns in some of the transgenic plants. After cloning and sequencing the AL-PCR products, the junctions between plant genomic DNA and the T-DNA insert could be analysed in great detail. For example it was shown that upon T-DNA integration a 66 bp genomic sequence was deleted, and no filler DNA was inserted. Primers located within the left and right flanking genomic DNA in transgenic shallot plants were used to recover the target site of T-DNA integration.
Collapse
Affiliation(s)
- S J Zheng
- Plant Research International, Wageningen University and Research Center, The Netherlands
| | | | | | | | | | | |
Collapse
|
49
|
Ali SN, Huigen DJ, Jacobsen E, Visser RG. Genomic in situ hybridization analysis of a trigenomic hybrid involving Solanum and Lycopersicon species. Genome 2001; 44:299-304. [PMID: 11341741 DOI: 10.1139/g00-114] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A 4x potato (+) tomato fusion hybrid (2n = 4x = 48) was successfully backcrossed with a diploid Lycopersicon pennellii (2n = 2x = 24). Genomic in situ hybridization (GISH) on somatic and meiotic chromosomes confirmed that the progenies were triploids (2n = 3x = 36) and possessed three different genomes: potato, tomato, and L. pennellii. Therefore, they have been called trigenomic hybrids. Total genomic probes of both Lycopersicon species were found to hybridize mutually, whereas the potato genome was clearly differentiated. During metaphase I, bivalents were formed predominantly between tomato and L. pennellii chromosomes and the univalents of potato chromosomes were most common. Trivalents in all cases included homoeologous chromosomes of potato, tomato, and L. pennellii. However, the triploids were totally sterile as determined from extensive crossing. On chromosome doubling of triploids by shoot regeneration from callus, hexaploids (2n = 6x = 72) were obtained. Despite exhibiting clear allohexaploid behaviour by forming 36 bivalents at meiosis, these were also completely sterile like their triploid counterparts. In spite of this drawback, the prospects of chromosome pairing between potato L. pennellii and Solanum genomes does open the possibilities for bringing the two genera close.
Collapse
Affiliation(s)
- S N Ali
- Laboratory of Plant Breeding, Wageningen University, The Netherlands.
| | | | | | | |
Collapse
|
50
|
Lassen K, Jacobsen E, Busund LT, Kjaeve J. [Air in the portal vein and necrosis of the ventricle]. Tidsskr Nor Laegeforen 2001; 121:181-3. [PMID: 11475195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023] Open
Abstract
BACKGROUND Air in the portal vein is a serious sign, usually caused by enteric necrosis. METHODS The case report presents a 69-year-old male who died shortly after arrival in our department. RESULTS Abdominal CT scan showed hepatic portal venous gas, and thrombi in the superior mesenteric artery, the coeliac trunk and in the left iliac artery. Autopsy revealed a necrotic stomach but viable small bowel. INTERPRETATION Differential diagnoses are discussed, and we conclude that the patient most probably died from ischaemic necrosis. In severely ill patients, hepatic portal venous gas is an indication for urgent laparotomy.
Collapse
Affiliation(s)
- K Lassen
- Avdeling for gastroenterologisk kirurgi, Regionsykehuset i Tromsø 9037 Tromsø.
| | | | | | | |
Collapse
|